Therefore, the synergistic effects of quercetin and PTS could involve the modulation of superoxide dismutase and Bcl-2 to sensitize CRC xenografts towards chemotherapy and/or radiotherapy. The gene discussed is BCL2; the disease is colorectal carcinoma.